Skip to main content
logo
Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
21.20
-0.14 (-0.66%)
At close: Jul 31, 2026, 4:00 PM EDT
21.13
-0.07 (-0.33%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Biodesix Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
96.188.571.3249.0938.2154.51
Revenue Growth
29.05%24.08%45.30%28.46%-29.89%19.64%
Gross Profit
78.8871.7855.7536.0824.0623.99
Operating Income
-24.94-27.87-34.5-41.34-50.59-40.94
Net Income
-31.96-35.27-42.93-52.15-65.45-43.16
Earnings Per Share
-4.06-4.67-6.64-12.80-31.00-31.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
25.5718.9926.2526.2843.0932.71
Total Debt
71.6172.8561.9860.6931.8510.01
Net Cash (Debt)
-46.04-53.87-35.73-34.4111.2422.7
Net Cash Growth
-----50.49%-33.93%
Net Cash Per Share
-5.66-7.13-5.52-8.385.3416.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.88-23.27-48.65-22.87-44.97-28.22
Capital Expenditures
-0.27-0.26-3.23-22.92-3.3-2.24
Free Cash Flow
-9.15-23.53-51.88-45.79-48.27-30.46
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
82.08%81.11%78.17%73.50%62.96%44.01%
Operating Margin
-25.95%-31.50%-48.37%-84.22%-132.38%-75.11%
Pretax Margin
-33.26%-39.85%-60.19%-106.23%-171.27%-79.18%
Profit Margin
-33.26%-39.85%-60.19%-106.23%-171.27%-79.18%
FCF Margin
-9.52%-26.59%-72.74%-93.28%-126.32%-55.89%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2.280.633.123.614.672.99